GrupoPikolin, S.L. acquired 24.94% stake in Pangaea Oncology, S.A. (BME:PANG) from Mercantile Ebrosol Inversiones, S.L.U. on January 3, 2017. GrupoPikolin, S.L. acquired 2.64 million shares of Pangaea Oncology, S.A. As of October 23, 2016, the Real Decreto Legislativo approved the deal. GrupoPikolin, S.L. completed the acquisition of 24.94% stake in Pangaea Oncology, S.A. (BME:PANG) from Mercantile Ebrosol Inversiones, S.L.U. on January 3, 2017.